Citations (60)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (7)
Farhad Lotfi, Fatemeh Khodabandeh, Abdosaleh Jafari, Mehdi Rezaee, Hamed Rahimi, Zahra Shiravani & Khosro Keshavarz. (2023) Economic burden of cervical cancer and premalignant lesions associated with human papilloma virus: a societal perspective. Expert Review of Pharmacoeconomics & Outcomes Research 23:4, pages 439-447.
Read now
Read now
S. Rachel Skinner, Dan Apter, Newton De Carvalho, Diane M. Harper, Ryo Konno, Jorma Paavonen, Barbara Romanowski, Cecilia Roteli-Martins, Nansa Burlet, Attila Mihalyi & Frank Struyf. (2016) Human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine for the prevention of cervical cancer and HPV-related diseases. Expert Review of Vaccines 15:3, pages 367-387.
Read now
Read now
Emmanuelle Préaud & Nathalie Largeron. (2013) Economic burden of non-cervical cancers attributable to human papillomavirus: a European scoping review. Journal of Medical Economics 16:6, pages 763-776.
Read now
Read now
Anne Szarewski. (2010) HPV vaccine: Cervarix. Expert Opinion on Biological Therapy 10:3, pages 477-487.
Read now
Read now
M. Merito, N. Largeron, C. Cohet, L. Timelli, F. Boselli, A. Matteelli, L. Naldi & G. Vittori. (2008) Treatment patterns and associated costs for genital warts in Italy. Current Medical Research and Opinion 24:11, pages 3175-3183.
Read now
Read now
Thomas D. Szucs, Nathalie Largeron, Konstantin J. Dedes, Rachid Rafia & Stève Bénard. (2008) Cost-effectiveness analysis of adding a quadrivalent HPV vaccine to the cervical cancer screening programme in Switzerland. Current Medical Research and Opinion 24:5, pages 1473-1483.
Read now
Read now
Lieven Annemans, Vanessa Rémy, Emilie Lamure, Erik Spaepen, Mark Lamotte, Jean-Paul Muchada & Nathalie Largeron. (2008) Economic burden associated with the management of cervical cancer, cervical dysplasia and genital warts in Belgium. Journal of Medical Economics 11:1, pages 135-150.
Read now
Read now
Articles from other publishers (53)
G. Fabiano, A. Marcellusi, F. S. Mennini, P. Sciattella & G. Favato. (2022) Hospital resource utilisation from HPV-related diseases in England: a real-world cost analysis. The European Journal of Health Economics 24:1, pages 75-80.
Crossref
Crossref
Kwame Owusu-EduseiCody PalmerOlga Ovcinnikova, Giampiero Favato & Vincent Daniels. (2022) Assessing the Health and Economic Outcomes of a 9-Valent HPV Vaccination Program in the United Kingdom. Journal of Health Economics and Outcomes Research 9:1, pages 140-150.
Crossref
Crossref
Kwame Owusu-Edusei, Cody Palmer, Olga Ovcinnikova, Giampiero Favato & Vincent Daniels. (2022) Assessing the Health and Economic Outcomes of a 9-Valent HPV Vaccination Program in the United Kingdom. Journal of Health Economics and Outcomes Research 9:1.
Crossref
Crossref
Sarah CooperSarah Cooper. 2022. Analysing Gender in Healthcare. Analysing Gender in Healthcare
67
118
.
Samik Datta, Joshua Pink, Graham F. Medley, Stavros Petrou, Sophie Staniszewska, Martin Underwood, Pam Sonnenberg & Matt J. Keeling. (2019) Assessing the cost-effectiveness of HPV vaccination strategies for adolescent girls and boys in the UK. BMC Infectious Diseases 19:1.
Crossref
Crossref
Koh Jun Ong, Marta Checchi, Lorna Burns, Charlotte Pavitt, Maarten J Postma & Mark Jit. (2019) Systematic review and evidence synthesis of non-cervical human papillomavirus-related disease health system costs and quality of life estimates. Sexually Transmitted Infections 95:1, pages 28-35.
Crossref
Crossref
Talía Malagón & Eduardo L. Franco. 2018. Recurrent Respiratory Papillomatosis. Recurrent Respiratory Papillomatosis
59
94
.
Oscar Gamboa & Raúl Murillo. (2016) Estimación de la carga económica de las lesiones preneoplásicas y el cáncer de cuello uterino en Colombia. Implicaciones para la vacunación contra el VPH. Revista Colombiana de Cancerología 20:2, pages 61-72.
Crossref
Crossref
Elizabeth Thurgar, Samantha Barton, Charlotta Karner & Steven J Edwards. (2016) Clinical effectiveness and cost-effectiveness of interventions for the treatment of anogenital warts: systematic review and economic evaluation. Health Technology Assessment 20:24, pages 1-486.
Crossref
Crossref
VAH Coles, R Chapman, T Lanitis & SM Carroll. (2015) The costs of managing genital warts in the UK by devolved nation: England, Scotland, Wales and Northern Ireland. International Journal of STD & AIDS 27:1, pages 51-57.
Crossref
Crossref
Riccardo A. Audisio, Giancarlo Icardi, Andrea M. Isidori, Carlo A. Liverani, Alberto Lombardi, Luciano Mariani, Francesco Saverio Mennini, David A. Mitchell, Andrea Peracino, Sergio Pecorelli, Giovanni Rezza, Carlo Signorelli, Giovanni Vitali Rosati & Gian Vincenzo Zuccotti. (2016) Public health value of universal HPV vaccination. Critical Reviews in Oncology/Hematology 97, pages 157-167.
Crossref
Crossref
Ellinor ?stensson, Maria Fr?berg, Amy Leval, Ann-Cathrin Hellstr?m, Magnus B?cklund, Niklas Zethraeus & Sonia Andersson. (2015) Cost of Preventing, Managing, and Treating Human Papillomavirus (HPV)-Related Diseases in Sweden before the Introduction of Quadrivalent HPV Vaccination. PLOS ONE 10:9, pages e0139062.
Crossref
Crossref
D. Scott LaMontagne, Emmanuel Mugisha, Yuanji Pan, Edward Kumakech, Aloysius Ssemaganda, Troy J. Kemp, Jane Cover, Ligia A. Pinto & Mahboobeh Safaeian. (2014) Immunogenicity of bivalent HPV vaccine among partially vaccinated young adolescent girls in Uganda. Vaccine 32:47, pages 6303-6311.
Crossref
Crossref
Maria Michela Gianino, Sergio Delmonte, Emanuela Lovato, Morena Martinese, Sabrina Rondoletti, Maria Grazia Bernengo & Carla Maria Zotti. (2013) A retrospective analysis of the costs and management of genital warts in Italy. BMC Infectious Diseases 13:1.
Crossref
Crossref
Hugo C. Turner, Iacopo Baussano & Geoff P. Garnett. (2013) Vaccinating Women Previously Exposed to Human Papillomavirus: A Cost-Effectiveness Analysis of the Bivalent Vaccine. PLoS ONE 8:9, pages e75552.
Crossref
Crossref
Tom Glass Hopkins & Nick Wood. (2013) Female human papillomavirus (HPV) vaccination: Global uptake and the impact of attitudes. Vaccine 31:13, pages 1673-1679.
Crossref
Crossref
Keith Cooper, Jonathan Shepherd, Jo Picot, Jeremy Jones, Josephine Kavanagh, Angela Harden, Elaine Barnett-Page, Andrew Clegg, Debbie Hartwell, Geoff Frampton & Alison Price. (2012) AN ECONOMIC MODEL OF SCHOOL-BASED BEHAVIORAL INTERVENTIONS TO PREVENT SEXUALLY TRANSMITTED INFECTIONS. International Journal of Technology Assessment in Health Care 28:4, pages 407-414.
Crossref
Crossref
Emma Collins. (2012) Sexually transmitted infections (6/6): genital warts. British Journal of Healthcare Assistants 6:4, pages 182-185.
Crossref
Crossref
T Lanitis, S Carroll, C O'Mahony, F Charman, J M Khalid, V Griffiths & R E Brown. (2012) The cost of managing genital warts in the UK. International Journal of STD & AIDS 23:3, pages 189-194.
Crossref
Crossref
Adam J.N. Raymakers, Mohsen Sadatsafavi, Fawziah Marra & Carlo A. Marra. (2012) Economic and Humanistic Burden of External Genital Warts. PharmacoEconomics 30:1, pages 1-16.
Crossref
Crossref
D Scott LaMontagneSandhya BargeNga Thi LeEmmanuel MugishaMary E PennySanjay GandhiAmynah JanmohamedEdward KumakechN Rocio MosqueiraNghi Quy NguyenProma PaulYuxiao TangTran Hung MinhBella Patel UttekarAisha O Jumaan. (2011) Human papillomavirus vaccine delivery strategies that achieved high coverage in low- and middle-income countries. Bulletin of the World Health Organization 89:11, pages 821-830B.
Crossref
Crossref
Y. L. Woo, C. Badley, E. Jackson & R. Crawford. (2011) Long-term cytological and histological outcomes in women managed with loop excision treatment under local anaesthetic for high-grade cervical intraepithelial neoplasia. Cytopathology 22:5, pages 334-339.
Crossref
Crossref
Yin Ling Woo & Siti Z. Omar. (2011) Human papillomavirus vaccination in the resourced and resource-constrained world. Best Practice & Research Clinical Obstetrics & Gynaecology 25:5, pages 597-603.
Crossref
Crossref
C.D. Scarbrough Lefebvre, G. Van Kriekinge, M.A. Gonçalves & S. de Sanjose. (2011) Appraisal of the burden of genital warts from a healthcare and individual patient perspective. Public Health 125:7, pages 464-475.
Crossref
Crossref
Ruth Chapman, Kate Soldan & Mark Jit. (2011) Modelling borderline and mild dysplasia associated with HPV 6 and 11 infection. Vaccine 29:16, pages 2881-2886.
Crossref
Crossref
Israel Alfonso-Trujillo, Mar?a Elena Gonz?lez Solares, Andrea Patricia Vital Acosta & Mar?a del Carmen Toledo Garc?a. (2010) Condiloma acuminado alrededor de la ileostom?a. Piel 25:10, pages 565-567.
Crossref
Crossref
Gabriella Ferrandina, Andrea Marcellusi, Francesco Saverio Mennini, Marco Petrillo, Carlo Di Falco & Giovanni Scambia. (2010) Hospital costs incurred by the Italian National Health Service for invasive cervical cancer. Gynecologic Oncology 119:2, pages 243-249.
Crossref
Crossref
Aureli Blade, Montserrat Cararach, María Castro, Ferrán Catalá-López, Isabel Pérez-Escolano & Silvia de Sanjosé. (2010) Clinical Management of Abnormal Cytology Test Results and Costs Associated With the Prevention of Cervical Cancer in Spain. Journal of Lower Genital Tract Disease 14:4, pages 311-318.
Crossref
Crossref
Chao-Hsiun Tang, Raoh-Fang Pwu, I-Ching Tsai, Han-I Wang, San-Lin You, Chi-An Chen, Paul A. Scuffham, Chang-Yao Hsieh, Cheng-Yang Chou, Sheue-Rong Lin, Yao-Der Chen & Chien-Jen Chen. (2009) Costs of cervical cancer and precancerous lesions treatment in a publicly financed health care system. Archives of Gynecology and Obstetrics 281:4, pages 683-695.
Crossref
Crossref
Xavier Castellsagué, María San Martín, Antonio González & Miguel Ángel Casado. (2010) Epidemiología de las lesiones precancerosas y verrugas genitales asociadas a infección por virus del papiloma humano en España. Progresos de Obstetricia y Ginecología 53:3, pages 81-87.
Crossref
Crossref
I. Alfonso-Trujillo, M. ?lvarez Labrada, ?.R. Guti?rrez Rojas, M.A. Rodr?guez Garc?a & S. Collazo Caballero. (2009) Condiloma acuminado: eficacia terap?utica comparativa entre el 5-fluorouracilo t?pico y la criocirug?a. SEMERGEN - Medicina de Familia 35:10, pages 484-488.
Crossref
Crossref
Georgi Tchernev. (2009) Sexually transmitted papillomavirus infections: epidemiology pathogenesis, clinic, morphology, important differential diagnostic aspects, current diagnostic and treatment options. Anais Brasileiros de Dermatologia 84:4, pages 377-389.
Crossref
Crossref
Sarah C. Woodhall, Mark Jit, Chun Cai, Tina Ramsey, Sadique Zia, Simon Crouch, Yvonne Birks, Robert Newton, W John Edmunds & Charles J. N. Lacey. (2009) Cost of Treatment and QALYs Lost Due to Genital Warts: Data for the Economic Evaluation of HPV Vaccines in the United Kingdom. Sexually Transmitted Diseases 36:8, pages 515-521.
Crossref
Crossref
Dhinagar Subramanian, Karine Szwarcensztein, Josephine A. Mauskopf & Mark C. Slack. (2009) Rate, type, and cost of pelvic organ prolapse surgery in Germany, France, and England. European Journal of Obstetrics & Gynecology and Reproductive Biology 144:2, pages 177-181.
Crossref
Crossref
Israel Alfonso-Trujillo, Mar?a Antonia Rodr?guez Garc?a, ?ngela Rosa Guti?rrez, Doraiquis Acosta Medina, Marianlie Navarro Maestre & Sonia Collazo Caballero. (2009) ??cido tricloroac?tico o criocirug?a en el tratamiento del condiloma acuminado?. Piel 24:4, pages 176-180.
Crossref
Crossref
Alessandro Ricciardi, Nathalie Largeron, Paolo Giorgi Rossi, Mimma Raffaele, Catherine Cohet, Antonio FedericiFabio Palazzo. (2018) Incidence of Invasive Cervical Cancer and Direct Costs Associated with its Management in Italy. Tumori Journal 95:2, pages 146-152.
Crossref
Crossref
Xavier Castellsagué, Vanessa Rémy, Luis M. Puig-Tintoré, Ricardo Sainz de la Cuesta, Nuria Gonzalez-Rojas & Catherine Cohet. (2009) Epidemiology and Costs of Screening and Management of Precancerous Lesions of the Cervix in Spain. Journal of Lower Genital Tract Disease 13:1, pages 38-45.
Crossref
Crossref
Xavier Castellsagué, Catherine Cohet, Luis M Puig-Tintoré, Luis Olmos Acebes, Jesus Salinas, Maria San Martin, Lusine Breitscheidel & Vanessa Rémy. (2009) Epidemiology and cost of treatment of genital warts in Spain. European Journal of Public Health 19:1, pages 106-110.
Crossref
Crossref
Herve Fernandez, Martin Farrugia, Siân E. Jones, Josephine A. Mauskopf, Peter Oppelt & Dhinagar Subramanian. (2009) Rate, Type, and Cost of Invasive Interventions for Uterine Myomas in Germany, France, and England. Journal of Minimally Invasive Gynecology 16:1, pages 40-46.
Crossref
Crossref
M. Stanley. (2008) HPV vaccines: are they the answer?. British Medical Bulletin 88:1, pages 59-74.
Crossref
Crossref
Peter Hillemanns, J Gabrielle Breugelmans, Friederike Gieseking, Stève Bénard, Emilie Lamure, Kavi J Littlewood & Karl U Petry. (2008) Estimation of the incidence of genital warts and the cost of illness in Germany: A cross-sectional study. BMC Infectious Diseases 8:1.
Crossref
Crossref
Anna R. Giuliano, Guillermo Tortolero-Luna, Elena Ferrer, Ann N. Burchell, Silvia de Sanjose, Susanne Kruger Kjaer, Nubia Mu?oz, Mark Schiffman & F. Xavier Bosch. (2008) Epidemiology of Human Papillomavirus Infection in Men, Cancers other than Cervical and Benign Conditions. Vaccine 26, pages K17-K28.
Crossref
Crossref
Paolo Bonanni, Sara Boccalini & Angela Bechini. (2008) The expected impact of new vaccines and vaccination policies. Journal of Public Health 16:4, pages 253-259.
Crossref
Crossref
Ian H. Frazer. (2008) HPV vaccines and the prevention of cervical cancer. Update on Cancer Therapeutics 3:1, pages 43-48.
Crossref
Crossref
A. Tejera-Vaquerizo, R.J. Bosch-García, A. Fernández-Orland & E. Herrera-Ceballos. (2008) Resolución de condilomas acuminados recalcitrantes en un paciente infectado por el virus de la inmunodeficiencia humana tratado con cidofovir tópico. Actas Dermo-Sifiliográficas 99:2, pages 162-163.
Crossref
Crossref
A. Tejera-Vaquerizo, R.J. Bosch-García, A. Fernández-Orland & E. Herrera-Ceballos. (2008) Resolution of Recalcitrant Condylomata Acuminata in a Patient With Human Immunodeficiency Virus Treated With Topical Cidofovir. Actas Dermo-Sifiliográficas (English Edition) 99:2, pages 162-163.
Crossref
Crossref
Susanne?Kr?ger Kj?r, Trung?Nam Tran, Par Sparen, Laufey Tryggvadottir, Christian Munk, Erik Dasbach, Kai?Li Liaw, Jan Nyg?rd & Mari Nyg?rd. (2007) The Burden of Genital Warts: A Study of Nearly 70,000 Women from the General Female Population in the 4 Nordic Countries. The Journal of Infectious Diseases 196:10, pages 1447-1454.
Crossref
Crossref
Gary Michael Ginsberg, Menachem Fisher, Inbar Ben-Shahar & Jacob Bornstein. (2007) Cost?utility analysis of vaccination against HPV in Israel. Vaccine 25:37-38, pages 6677-6691.
Crossref
Crossref
Marc Brisson, Nicolas Van de Velde, Philippe De Wals & Marie-Claude Boily. (2007) The potential cost-effectiveness of prophylactic human papillomavirus vaccines in Canada. Vaccine 25:29, pages 5399-5408.
Crossref
Crossref
Anthony T Newall, Philippe Beutels, James G Wood, W John Edmunds & C Raina MacIntyre. (2007) Cost-effectiveness analyses of human papillomavirus vaccination. The Lancet Infectious Diseases 7:4, pages 289-296.
Crossref
Crossref
J. -G. Breugelmans. 2007. Traité des infections et pathologies génitales à papillomavirus. Traité des infections et pathologies génitales à papillomavirus
385
391
.
PD Griffiths. (2006) Anticipating full benefits from the new papillomavirus vaccines. Reviews in Medical Virology 17:1, pages 1-3.
Crossref
Crossref
Silvano Costa & Giampiero Favato. (2008) Evaluation of the Economic Impact Produced by the Prevention of Events Induced by the HPV 6-11 Virus Types Contained in the Quadrivalent Vaccine. SSRN Electronic Journal.
Crossref
Crossref